-
IntroducedFeb 02, 2026
-
Passed HouseFeb 26, 2026
-
Passed Senate
-
Became Law
Maryland House Bill
Public Health - Maryland Pediatric Cancer Fund - Entities Eligible for Grants
Last Action See all actions
Senate • Feb 27, 2026: Referred Finance
Latest Bill Text See all bill texts
Summary
Comments on HB 672
Tweets
Whip Lists
Sponsors



- Bagnallcosponsor
- Cullisoncosponsor
- Guzzonecosponsor
- Hillcosponsor
- Hutchinsoncosponsor
- S. Johnsoncosponsor
- Kaufmancosponsor
- Kipkecosponsor
- Lopezcosponsor
- Martinezcosponsor
- Reillycosponsor
- Rosscosponsor
- Taverascosponsor
- White Hollandcosponsor
- Woormancosponsor
Votes
Actions
- Feb 27, 2026 | Senate
- Referred Finance
- Feb 26, 2026 | House
- Third Reading Passed (135-1)
- Feb 24, 2026 | House
- Favorable with Amendments {233825/1 Adopted
- Second Reading Passed with Amendments
- Feb 23, 2026 | House
- Favorable with Amendments Report by Health
- Feb 17, 2026 | House
- Hearing canceled
- Hearing 2/17 at 2:00 p.m.
- Feb 05, 2026 | House
- Hearing 2/17 at 1:00 p.m.
- Feb 02, 2026 | House
- First Reading Health
Documents
- Fiscal and Policy NotePDF
- Vote - House - Committee - HealthPDF
- Witness ListHTML
- HLT Testimony, FAV -- Hoffman, Ruth (Pediatric Cancer Research Commission)
- HLT In Person - Oral Testimony, FAV -- Hoffman, Ruth (American Childhood Cancer Organization)
- HLT In Person - Oral Testimony, FAV -- Small, Donald (Johns Hopkins University School of Medicine)
- HLT Virtual - Oral Testimony, FAV -- Lewis, Donna (American Childhood Cancer Organization)
- HLT In Person - Oral Testimony, FAV -- Shetty, Emily
- HLT Testimony, FAV -- Ortiz, Jeanette (University of Maryland, Baltimore)
- HLT Testimony, FAV -- Lynch, Meghan (Maryland Department of Health)
